Pharmaceutical Intermediates
- • Analgesics (59)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (118)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (427)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (106)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (63)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (476)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9764)
- • Bulk Drug Intermediates (17748)
Related News
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
2026-07-16 -
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
2026-07-14 -
Premium Global Chemical Sourcing Requests (16-19July, 2026)
2026-07-20 -
Premium Global Chemical Sourcing Requests (13-15July, 2026)
2026-07-16 -
Premium Global Chemical Sourcing Requests (9-13July, 2026)
2026-07-13 -
China's SBR Prices Rise Driven by Costs
2026-07-22
Anti-Addiction Agents
2-Indanone
(615-13-4)-
Pharmaceutical Grade / 99.5%
-
- / 99.00%
-
industrial Grade / 98%
-
Industrial Grade / 99%
Request for quotation , get quotes from more suppliers.
-
Industrial Grade, Feed Grade, Food Grade, Pharma Grade / 99%
-
- / 99.00%
-
-
Request for quotation , get quotes from more suppliers.
2-(5-Norborene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate
(125700-73-4)-
Pharmaceutical Grade / 99%
-
Industrial Grade,Pharma Grade / 99%
-
- / 99.00%
-
Industrial Grade / 99.0%
Request for quotation , get quotes from more suppliers.
-
Industrial Grade / pharmaceutical grade / 99%
$1/MT EXW
-
- / 99.00%
-
Industrial Grade / 99%
-
Request for quotation , get quotes from more suppliers.
Oxazol-2-ylboronic acid
(891660-66-5)-
Industrial Grade / pharmaceutical grade / 99%
$1/MT EXW
-
Industrial Grade / 99.00%
-
-
Request for quotation , get quotes from more suppliers.
Source Anti-Addiction Agents Products Supply
(S)-(+)-2,2'-Bis[di(3,5-di-i-propyl-4-dimethylaminophenyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl,min.97%
(919338-66-2)-
Industrial Grade / 99%
-
Industrial Grade / 99%
-
-
Request for quotation , get quotes from more suppliers.
-
-
-
reagent grade / 98%
$110/G EXW
-
Request for quotation , get quotes from more suppliers.
More Information
Anti-addiction agents are substances used to help reduce dependence on addictive substances such as opioids, alcohol, nicotine, or other drugs. They are widely applied in pharmaceutical formulations, clinical treatments, and research studies to assist in safe and controlled withdrawal.
The mechanisms of action for anti-addiction agents vary by type:
• Opioid receptor antagonists block the effects of opioids, helping to reduce cravings and prevent relapse.
• Nicotine replacement agents deliver controlled doses of nicotine to reduce withdrawal symptoms in tobacco users.
• Alcohol deterrent agents interfere with alcohol metabolism, creating unpleasant effects to discourage consumption.
• Other receptor modulators regulate neurotransmitter activity to manage addiction-related behavior and cravings.
Factors to consider when selecting anti-addiction agents:
• Effectiveness in reducing dependence and managing withdrawal symptoms.
• Safety, including potential side effects, toxicity, and patient tolerance.
• Compatibility with other medications or active ingredients.
• Regulatory compliance to meet pharmaceutical and medical standards.
Common forms include tablets, capsules, powders, and injectable solutions, enabling versatile applications in pharmaceuticals, healthcare, and research.
Frequently Asked Questions
Anti-Addiction Agents are pharmacological compounds designed to help individuals reduce or cease dependence on addictive substances such as opioids, alcohol, or nicotine. These agents work by targeting specific neurotransmitter systems in the brain to alleviate withdrawal symptoms, reduce cravings, or block the rewarding effects of the substance. Common examples include methadone, buprenorphine, naltrexone, and acamprosate.
Anti-Addiction Agents support recovery by stabilizing brain chemistry, reducing withdrawal discomfort, and decreasing the reinforcing effects of addictive substances. For instance, opioid agonists like methadone prevent withdrawal without producing euphoria, while antagonists like naltrexone block opioid receptors to deter relapse. When combined with behavioral therapy and counseling, these medications significantly improve long-term recovery outcomes.
When sourcing Anti-Addiction Agents, consider the following:1. Regulatory compliance—ensure the supplier adheres to FDA, EMA, or other relevant pharmacopeial standards.2. Purity and documentation—request certificates of analysis (CoA) and GMP compliance records.3. Supplier reliability—including consistent batch quality, secure supply chain, and technical support.4. Intended application—verify that the compound meets specifications for either clinical formulation or preclinical research.
Yes, Anti-Addiction Agents are tailored to specific addictions:- Opioid use disorder: methadone, buprenorphine, naltrexone- Alcohol use disorder: naltrexone, acamprosate, disulfiram- Nicotine dependence: varenicline, bupropionEach agent works through distinct mechanisms—such as receptor agonism, antagonism, or modulation of dopamine pathways—to address the unique neurobiology of each addiction type.